Abstract
To the Editor:
With great interest we read the study by Sramek et al,1 in which they showed that patients with type 3 von Willebrand disease, characterized by an absence of circulating von Willebrand factor (vWF), were not protected against atherosclerosis. The patients in their study were young (mean age 35 years), whereas clinically relevant atherosclerosis typically occurs at a later age. Therefore, we would like to present our study on the association between vWF and atherosclerosis in an elderly population.
[...]
With great interest we read the study by Sramek et al,1 in which they showed that patients with type 3 von Willebrand disease, characterized by an absence of circulating von Willebrand factor (vWF), were not protected against atherosclerosis. The patients in their study were young (mean age 35 years), whereas clinically relevant atherosclerosis typically occurs at a later age. Therefore, we would like to present our study on the association between vWF and atherosclerosis in an elderly population.
[...]
| Original language | English |
|---|---|
| Pages (from-to) | e57 |
| Journal | Circulation |
| Volume | 110 |
| Issue number | 5 |
| DOIs |
|
| Publication status | Published - 3 Aug 2004 |